参考文献/References:
[1]Blondeau N,Lai Y,Tyndall S,et al.Distribution of sphingosine kinase activity and mRNA in rodent brain[J].Journal of Neurochemistry,2010,103(2):509-517. [2]Dimasi David P,Pitson Stuart M,Bonder Claudine S.Examining the Role of Sphingosine Kinase-2 in the Regulation of Endothelial Cell Barrier Integrity[J].Microcirculation,2016(23):248-265. [3]Schuhmann Michael K,Krstic M,Kleinschnitz C,et al.Fingolimod(FTY720)Reduces Cortical Infarction and Neurological Deficits During Ischemic Stroke Through Potential Maintenance of Microvascular Patency[J].Curr Neurovasc Res,2016(13):277-282. [4]Gaire BP,Choi JW.Sphingosine 1-Phosphate Receptors in Cerebral Ischemia[J].Neuromolecular Med,2020. [5]Wacker BK,Freie AB,Perfater JL,et al.Junctional Protein Regulation by Sphingosine Kinase 2 Contributes to Blood-Brain Barrier Protection in Hypoxic Preconditioning-Induced Cerebral Ischemic Tolerance[J].Journal of Cerebral Blood Flow&Metabolism,2012,32(6):1014-1023. [6]Chen JL,Wang XX,Chen L,et al.A sphingosine kinase 2-mimicking TAT-peptide protects neurons against ischemia-reperfusion injury by activating BNIP3-mediated mitophagy[J].Neuropharmacology,2020(181):108326. [7]Song DD,Zhang TT,Chen JL,et al.Sphingosine kinase 2 activates autophagy and protects neurons against ischemic injury through interaction with Bcl-2 via its putative BH3 domain[J].Cell Death&Disease,2017,8(7):e2912. [8]Di G,Wang Z,Wang W,et al.AntagomiR-613 protects neuronal cells from oxygen glucose deprivation/re-oxygenation via increasing SphK2 expression[J].Biochemical&Biophysical Research Communications,2017,493(1):188-194. [9]Dorostkar MM,Zou C,Blazquez-Llorca L,et al.Analyzing dendritic spine pathology in Alzheimer’s disease:problems and opportunities[J].Acta Neuropathol,2015,130(1):1-19. [10]Dominguez G,Maddelein ML,Pucelle M,et al.Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer’s disease brain[J].Acta Neuropathol Commun,2018,6(1):25. [11]Lei M,Teo JD,Song H,et al.Sphingosine kinase 2 potentiates amyloid deposition but protects against hippocampal volume loss and demyelination in a mouse model of Alzheimer’s disease[J].The Journal of Neuroscience,2019,39(48):519-524. [12]Couttas TA,Kain N,Daniels B,et al.Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis[J].Acta Neuropathologica Communications,2014,2(1):9. [13]Jesko H,Wencel PL,Lukiw WJ,et al.Modulatory Effects of Fingolimod(FTY720)on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer’s Disease[J].Mol Neurobiol,2019,56(1):174-185. [14]Ryan BJ,Hoek S,Fon EA,et al.Mitochondrial dysfunction and mitophagy in Parkinson’s: from familial to sporadic disease[J].Trends Biochem Sci,2015(40):200-210. [15]Pyne S,Adams DR,Pyne NJ.Sphingosine Kinases as Druggable Targets[J].Handbook of Experimental Pharmacology,2020(259):49-76. [16]Sivasubramanian M,Kanagaraj N,Dheen ST,et al.Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson’s disease and in MPP+-treated MN9D cells in vitro[J].Neuroscience Oxford,2015(290):636-648. [17]Pyszko JA,Strosznajder JB.The key role of sphingosine kinases in the molecular mechanism of neuronal cell survival and death in an experimental model of Parkinson’s disease[J].Folia Neuropathol,2014,52(3):260-269. [18]Phillips GR,Hancock SE,Brown SHJ,et al.Cholesteryl ester levels are elevated in the caudate and putamen of Huntington’s disease patients[J].Sci Rep,2020(10):20314. [19]Moruno-Manchon JF,Uzor NE,Blasco-Conesa MP,et al.Inhibiting sphingosine kinase 2 mitigates mutant Huntingtin-induced neurodegeneration in neuron models of Huntington disease[J].Human Molecular Genetics,2017,26(7):1305-1317. [20]Song DD,Zhou JH,Sheng R.Regulation and function of sphingosine kinase 2 in diseases[J].Histology&Histopathology,2017(33):433-445. [21]Weigert A,Knethen AV,Thomas D,et al.Sphingosine kinase 2 is a negative regulator of inflammatory macrophage activation[J].Biochimica et Biophysica Acta(BBA)- Molecular and Cell Biology of Lipids,2019,1864(9):1235-1246. [22]Imeri F,Schwalm S,Lyck R,et al.Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis:Resistance to FTY720 but not ST-968 treatments[J].Neuropharmacology,2016(105):341-350. [23]Yang G,Gu M,Chen W,et al.SPHK-2 Promotes the Particle-Induced Inflammation of RAW264.7 by Maintaining Consistent Expression of TNF-α and IL-6[J].Inflammation,2018,41(9855):1-10. [24]Gaire BP.Sphingosine kinase 2 as the promising target for stroke research[J].Int J Stroke,2018,13(4):NP11-NP12.